Publications by authors named "Spyros Dourakis"

The 'alarm clock' for human beings in the era of climate medicine has rung. Original diseases have appeared, that could not be explained and attributed to common causes, which are suggested to be linked to global warming and environmental factors. Such an indolent disease is the chronic kidney disease of unknown cause (CKDu), introduced also as Mesoamerican or Uddanam nephropathy.

View Article and Find Full Text PDF

Background: Spontaneous bacterial peritonitis (SBP) is associated with a high mortality. The aim was to investigate whether bacterial deoxyribonucleic acid (bactDNA) could offer an accurate identification of pathogens and to explore its prognostic role during and early after an SBP episode.

Methods: Consecutive patients with SBP (SBP-group) and patients with decompensated cirrhosis without SBP/bacterascites (control-group) were enrolled.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic Hepatitis C infection is linked to various systemic diseases, including diabetes and liver fat accumulation, and recent studies suggest it may also contribute to atherosclerosis.
  • The virus induces an increase in inflammatory markers, such as tumor necrosis factor-a and interleukin-6, causing metabolic issues like insulin resistance and lipid buildup.
  • Oxidative stress plays a significant role in these metabolic problems, as the virus disrupts metal balance and promotes inflammation, highlighting the need to understand these effects for better management.
View Article and Find Full Text PDF

Background: Idiopathic non-cirrhotic portal hypertension (INCPH) is mainly associated with thrombophilia in Western countries. Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disease that manifests with hemolytic anemia, thrombosis, and peripheral blood cytopenias. Portal and hepatic venous thrombosis were reported in PNH.

View Article and Find Full Text PDF

It is widely known that liver cirrhosis, regardless of the etiologies is accompanied by severe hemodynamic changes. The principal pathophysiological mechanisms are the hyperdynamic circulation with increased cardiac output, heart rate along with reduced systemic vascular resistance. Thus, counteractive mechanisms may develop that eventually lead to systolic as well as diastolic dysfunction and rhythm disturbances, in order to keep a steady homeostasis in the human body.

View Article and Find Full Text PDF

Objectives: In cystic fibrosis (CF), liver disease (LD) is the third leading cause of mortality. As liver biopsy was considered inconsistent in CFLD diagnosis, a combination of modalities were utilized in the conventional Debray criteria (DC). More recently, noninvasive liver fibrosis biomarkers were applied by Koh et al (New criteria-NC).

View Article and Find Full Text PDF
Article Synopsis
  • Human beta-defensin-1 (hBD-1) levels were analyzed in patients with decompensated cirrhosis, particularly focusing on those with acute-on-chronic liver failure (ACLF), to assess their relationship with mortality.
  • The study included 125 patients split into three groups: those with ACLF, those with acute decompensation without ACLF, and those with stable decompensated cirrhosis, alongside healthy controls for comparison.
  • Results showed that higher levels of hBD-1 were linked to worse outcomes in ACLF patients, with hBD-1 emerging as a strong independent predictor of 60-day mortality, while other markers like C-reactive protein were not effective.
View Article and Find Full Text PDF

Objectives: Acute decompensation (AD) of cirrhosis is characterized by high mortality. We aimed to validate the performance in predicting mortality of both the chronic-liver-failure-consortium (CLIF-C) acute-on-chronic liver failure (ACLF) and CLIF-C AD scores in a cohort of patients admitted for AD.

Methods: In this prospective cohort study, patients were followed-up during their hospital stay and for 365 days thereafter.

View Article and Find Full Text PDF
Article Synopsis
  • Bacterial translocation (BT) contributes to infections in liver cirrhosis by allowing bacteria from the gut to enter the bloodstream, especially in cases where gut function is impaired.
  • Increased gut permeability and bacterial overgrowth are common in cirrhosis, leading to elevated levels of various BT markers like C-reactive protein and procalcitonin in patients.
  • High levels of these markers are linked to serious complications, including severe infections, liver failure, and higher mortality rates in individuals with cirrhosis.
View Article and Find Full Text PDF
Article Synopsis
  • Lipopolysaccharide-binding protein (LBP) is produced by the liver and changes in its levels relate to bacterial translocation and gut permeability in patients with decompensated cirrhosis (DC).
  • A study of 88 patients found that higher serum LBP levels indicated a significant correlation with infection, and specific levels effectively predicted the absence of infections like spontaneous bacterial peritonitis (SBP).
  • Elevated serum LBP was associated with an increased risk of mortality, indicating it can be a key marker for short-term mortality in non-infected patients with DC.
View Article and Find Full Text PDF

Aim: Acute-on-chronic liver failure (ACLF) is defined as an acute deterioration of liver disease with high mortality in patients with cirrhosis. The early mortality in ACLF is associated with organ failure and high leukocyte count. The time needed to reverse this condition and the factors affecting mortality after the early 30-day-period were evaluated.

View Article and Find Full Text PDF

Background: The incidence and severity of alcoholic liver disease (ALD) in chronic drinkers has been found to correlate with some environmental factors and especially with the dose of alcohol consumption, but it is obvious that other parameters clearly contribute to individual alcohol susceptibility. Chronic ethanol exposure leads to continuous endotoxin-mediated Toll-like receptor-4 (TLR-4) and CD14 activation and subsequent cytokine release resulting in chronic inflammation with continued hepatocellular damage. Therefore, genetic studies of polymorphism in TLR-4 and CD14 genes seem to be appropriate in determining genetic susceptibility to ALD.

View Article and Find Full Text PDF

Background: Cholangiocarcinoma is a very aggressive tumor with poor survival. Therefore, early diagnosis and surgical resection are of paramount importance. Its diagnosis is difficult because access to the tumor is not easy.

View Article and Find Full Text PDF

Background: In cirrhotic patients awaiting liver transplantation, serum sodium concentration is related to prognosis. However, abnormalities in sodium homeostasis are evident even in the early preascitic stage of cirrhosis. We aimed to investigate whether parameters of renal sodium handling (serum sodium, urinary sodium and fractional exertion of sodium (FeNa%) correlate with markers of liver function and renin-aldosterone axis activity in patients with preascitic cirrhosis without hyponatremia.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examined post embolization syndrome (PES) in 237 hepatocellular carcinoma patients treated with doxorubicin-loaded DC Bead, performing procedures every two months for a total of three sessions over six months.
  • - PES occurred in 86.5% of patients, with grade 2 PES affecting 25% to 42.19%, and fever was seen in 22.7% to 38.3% of cases; the intensity of PES was linked to the extent of embolization and baseline tumor size.
  • - Findings suggested that PES is indicative of tumor response rather than damage to healthy liver tissue, as it did not correlate with liver enzyme levels but did relate to tumor necrosis degree
View Article and Find Full Text PDF

Introduction: Complications of chemoembolization performed with DC Bead(™) loaded with doxorubicin (DEBDOX) of diameters 100-300 μm and 300-500 μm are presented in this paper. These diameters are currently the smallest available in drug-eluting technology.

Methods: Included are 237 patients who were treated with sequential DEBDOX with doxorubicin loaded at 37.

View Article and Find Full Text PDF

Aim: To translate into Greek and validate the chronic liver disease questionnaire (CLDQ).

Methods: Two hundred and six consecutive adult patients with the diagnosis of a chronic liver disease from 2 general hospitals in Athens were enrolled in the study from May to September 2008. In order to assess their quality of life (QOL) the CLDQ was applied.

View Article and Find Full Text PDF